Polyvalent melanoma vaccine

Details Polyvalent melanoma vaccine Polyvalent melanoma vaccine

1992-10-14

1999-03-16

Caputa, Anthony C.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Cancer cell or component thereof

4242481, 4242781, 435723, 435366, 435371, 530828, A61K 3900

Patent

active

058826548

ABSTRACT:
A new polyvalent melanoma cell vaccine is disclosed comprised of one or more allogeneic melanoma cell lines which contain effective concentrations of melanoma associated antigens. Further disclosed are a method of stimulating an immunological response by administering the described vaccine as well as a method of prognosticating a patient.

REFERENCES:
patent: 4233286 (1980-11-01), Soothill et al.
patent: 4557931 (1985-12-01), Irie et al.
patent: 4562160 (1985-12-01), Real et al.
patent: 5030621 (1991-07-01), Bystryn
patent: 5194384 (1993-03-01), Bystryn
patent: 5427664 (1995-06-01), Stoev et al.

Affiliated with

Also associated with

Rating

Polyvalent melanoma vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polyvalent melanoma vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyvalent melanoma vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-814891